Apparent Disparities in Hospital Admission and Biologic Use in the Management of Inflammatory Bowel Disease between 2014–2018 in Some Black and Ethnic Minority (BEM) Populations in England
Abstract
:1. Introduction
2. Methods
- White British
- White Irish
- White other
- Afro-Caribbean (often provided separately as African or Caribbean)
- Bangladeshi
- Indian
- Pakistani
- Croydon Health Services NHS Trust
- Kings College Hospital NHS Foundation Trust
- NorthWest Anglia NHS Foundation Trust
- Nottingham University Hospitals NHS Trust
- Queen Elizabeth Hospital King’s Lynn NHS Foundation Trust
- The Princess Alexandra Hospital NHS Trust
- University Hospitals of Birmingham NHS Foundation Trust
- University Hospitals of Bristol NHS Foundation Trust
- University Hospitals of Derby and Burton NHS Foundation Trust
- Wye Valley NHS Trust
3. Results
4. Discussion
5. Freedom of Information Requests
- Croydon Health Services NHS Trust F0I 1678
- Kings College Hospital NHS Foundation Trust FOI 6174 and 6266
- NorthWest Anglia NHS Foundation Trust FOI 2019/0482 and 2019—798
- Nottingham University Hospitals NHS Trust NUH 57316
- Queen Elizabeth Hospital King’s Lynn NHS Foundation Trust Specific response number not issued but results provided by IBD specialist nurse
- The Princess Alexandra Hospital NHS Trust FOI 19-513
- University Hospitals of Birmingham NHS Foundation Trust FOI 0281 2019/20
- University Hospitals of Bristol NHS Foundation Trust UHB 19-507
- University Hospitals of Derby and Burton NHS Foundation Trust FOI 19.674 and 19.697
- Wye Valley NHS Trust
Author Contributions
Funding
Conflicts of Interest
References
- Damas, O.M.; Jahann, D.A.; Reznik, R.; McCauley, J.L.; Tamariz, L.; Deshpande, A.R.; Abreu, M.T.; Sussman, D.A. Phenotypic manifestations of inflammatory bowel disease differ between Hispanics and non-Hispanic whites: Results of a large cohort study. Am. J. Gastroenterol. 2013, 108, 231–239. [Google Scholar]
- Farrukh, A.; Mayberry, J. Ethnic variations in the provision of biologic therapy for Crohn’s Disease: A freedom of information study. Med.-Leg. J. 2015, 83, 104–108. [Google Scholar] [PubMed]
- Farrukh, A.; Mayberry, J. Apparent discrimination in the provision of biologic therapy to patients with Crohn’s Disease according to ethnicity. Public Health 2015, 129, 460–464. [Google Scholar] [CrossRef] [PubMed]
- Flasar, M.H.; Johnson, T.; Roghmann, M.C.; Cross, R.K. Disparities in the use of immunomodulators and biologics for the treatment of inflammatory bowel disease; a retrospective cohort study. Inflamm. Bowel Dis. 2008, 14, 13–19. [Google Scholar] [PubMed]
- Jackson, J.F., 3rd; Dhere, T.; Repaka, A.; Shaukat, A.; Sitaraman, S. Crohn’s disease in an African-American population. Am. J. Med. Sci. 2008, 336, 389–392. [Google Scholar] [CrossRef] [PubMed]
- Nuguyen, G.C.; LaVeist, T.A.; Harris, M.L.; Wang, M.H.; Datta, L.W.; Brant, S.R. Racial disparities in utilization of specialist care and medications in inflammatory bowel disease. Am. J. Gastroenterol. 2010, 105, 2202–2208. [Google Scholar] [CrossRef] [PubMed]
- Farrukh, A.; Mayberry, J. Patients with ulcerative colitis from diverse populations: The Leicester Experience. Med.-Leg. J. 2016, 84, 31–35. [Google Scholar] [PubMed]
- King, D.; Rees, J.; Mytton, J.; Harvey, P.; Thomas, T.; Cooney, R.; Patel, P.; Trudgill, N. The outcomes of emergency admissions with ulcerative colitis between 2007 and 2017 in England. J. Crohn’s Colitis 2019. [Google Scholar] [CrossRef] [PubMed]
- Bhopal, R. Spectre of racism in health and health care. Lessons from history and the United States. BMJ 1988, 316, 1970–1973. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lear, J.T.; Lawrence, I.G.; Pohl, J.E.; Burden, A.C. Myocardial infarction and thrombolysis: A comparison of the Indian and European populations on a coronary care unit. J. R. Coll. Phys. Lond. 1994, 28, 143–147. [Google Scholar]
- Jack, R.H.; Davies, E.A.; Møller, H. Breast cancer incidence, stage, treatment and survival in ethnic groups in South East England. Br. J. Can. 2009, 100, 545–550. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Udavaraj, U.; Pruthi, R.; Casula, A.; Roderick, P. UK Renal Registry 16th annual report: Chapter 6 demographics and outcomes of patients from different ethnic groups on renal replacement therapy in the UK. Nephron Clin. Pract. 2013, 125, 111–126. [Google Scholar] [CrossRef] [PubMed]
- Das-Munshi, J.; Bhugra, D.; Crawford, M.J. Ethnic minority inequalities in access to treatments for schizophrenia and schizoaffective disorders: Findings from a nationally representative cross-sectional study. BMC Med. 2018, 16, 55. [Google Scholar] [CrossRef] [PubMed]
- Misra, R.; Limdi, J.; Cooney, R.; Sakuma, S.; Brookes, M.; Fogden, E.; Pattni, S.; Sharma, N.; Iqbal, T.; Munkholm, P.; et al. Ethnic differences in inflammatory bowel disease: Results from the United Kingdom inception cohort epidemiology study. World J. Gastroenterol. 2019, 25, 6145–6157. [Google Scholar] [CrossRef] [PubMed]
- NICE. ‘Summary of Technology Appraisal Decisions’ (NICE, 2016). Available online: nice.org.uk/about/what-we-do/our-programmes/nice-guidance/nice-technology-appraisal-guidance/summary-of-decisions (accessed on 27 May 2020).
- Bourke, G.; Worthy, B.; Hazell, R. Making freedom of information requests. In A Guide for Academic Researchers; The Constitution Unit, University College: London, UK, 2012. [Google Scholar]
- Council on Ethical and Judicial Affairs American Medical Association. Black-White disparities in health care. J. Am. Med. Assoc. 1990, 263, 2344–2346. [Google Scholar] [CrossRef] [PubMed]
- Geiger, H.J. Racial and ethnic disparities in diagnosis and treatment: A review of the evidence and consideration of causes. In Unequal Treatment: Confronting Racial and Ethnic Disparities in Healthcare; Smedley, B.D., Stith, A.Y., Nelson, A.R., Eds.; The National Academies Press Washington: Washington, DC, USA, 2003; pp. 417–454. [Google Scholar]
- Macpherson, W. The Stephen Lawrence Inquiry: Report of an Inquiry by Sir William Macpherson of Cluny (Command Papers, No. 4262-I), 1st ed.; The Stationary Office: London, UK, 1999. [Google Scholar]
- Collier, J. Tackling institutional racism. BMJ 1999, 318, 679. [Google Scholar] [PubMed] [Green Version]
- Salway, S.; Mir, G.; Turner, D.; Ellison, G.T.; Carter, L.; Gerrish, K. Obstacles to “Race Equality” in the English National Health Service: Insights from the Healthcare Commissioning Arena. Soc. Sci. Med. 2016, 152, 102–110. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Farrukh, A.; Mayberry, J. Does the failure to provide equitable access to treatment lead to action by NHS organisations: The case of biologics for South Asians with inflammatory bowel disease? Denn. Law J. 2019, 31, 77–91. [Google Scholar]
- Havard Institute for Healthcare Improvement. Does Racism Play a Role in Health Inequities? A Conversation between Donald Berwick, MD, and David R. Williams, PhD, MPH. 2018. Available online: ihi.org/Documents/OpenSchoolCourseTranscripts/David-Williams-Don-Berwick-Does-Racism-Play-A-Role-In-Health-Inequities.htm (accessed on 27 May 2020).
White British | White Irish | White Other | White | Afro-Caribbean | Asian | |
---|---|---|---|---|---|---|
Wye Valley NHS Trust | ||||||
In-Patient Admissions | ||||||
Population | 172,000 | 750 | 7200 | |||
Cases of IBD | 3368 | 24 | 112 | |||
Expected Cases of IBD | 3368 | 15 | 141 | |||
Proportion Statistic | 1.46 | −1.8 | ||||
Significance | n.s. | n.s. | ||||
University Hospitals of Bristol NHS Foundation Trust | ||||||
Use of Biologics | ||||||
Population | 334,000 | 3900 | 22,000 | 360,000 | 19,000 | |
Cases of IBD | 429 | 5 | 16 | 450 | <5 | |
Expected Cases of IBD | 429 | 5 | 28 | 450 | 24 | |
Proportion Statistic | 1.8 | −3.78 | ||||
Significance | n.s. | n.s. | p < 0.002 | |||
Queen Elizabeth Hospital King’s Lynn NHS Foundation Trust | ||||||
Use of Biologics | ||||||
Population | 136,000 | 444 | 3700 | |||
Cases of IBD | 165 | 3 | 8 | |||
Expected Cases of IBD | 165 | 1 | 5 | |||
Proportion Statistic | −1 | −0.8 | ||||
Significance | n.s. | n.s. | ||||
Croydon Health Services NHS Trust | ||||||
In-Patient Admissions | ||||||
Population | 172,000 | 5400 | 2300 | 180,000 | 60,500 | |
Cases of IBD | 1475 | 46 | 20 | 1706 | 230 | |
Expected Cases of IBD | 1475 | 63 | 168 | 573 | ||
Proportion Statistic | −1.6 | 11 | −61.4 | |||
Significance | n.s. | p < 0.0001 | p < 0.00001 | |||
Nottingham University Hospitals NHS Trust | ||||||
In-Patient Admissions | ||||||
Population | 276,000 | 14,100 | ||||
Cases of IBD | 5133 | 52 | ||||
Expected Cases of IBD | 5133 | 262 | ||||
Proportion Statistic | 9.4 | |||||
Significance | p < 0.00001 | |||||
University Hospitals of Derby and Burton NHS Foundation Trust | ||||||
In-Patient Admissions | ||||||
Population | 377,000 | 7500 | ||||
Cases of IBD | 16,111 | 69 | ||||
Expected Cases of IBD | 16,111 | 321 | ||||
Proportion Statistic | −12.9 | |||||
Significance | p < 0.00001 | |||||
University Hospitals of Birmingham NHS Foundation Trust | ||||||
Use of Biologics | ||||||
Population | 622,000 | 78,000 | ||||
Cases of IBD | 94 | 6 | ||||
Expected Cases of IBD | 94 | 12 | ||||
Proportion Statistic | −1.4 | |||||
Significance | n.s. | |||||
Kings College Hospital NHS Foundation Trust | ||||||
In-Patient Admissions | ||||||
Population | 170,000 | 78,500 | ||||
Cases of IBD | 13,003 | 2257 | ||||
Expected Cases of IBD | 13,003 | 6004 | ||||
Proportion Statistic | −42.3 | |||||
Significance | p < 0.00001 | |||||
NorthWest Anglia NHS Foundation Trust | ||||||
In-Patient Admissions | ||||||
Population | 159,000 | 1500 | 22,000 | 18,000 | ||
Cases of IBD | 8161 | 39 | 305 | 236 | ||
Expected Cases of IBD | 8161 | 77 | 1129 | 924 | ||
Proportion Statistic | −3.6 | −22.1 | −20.5 | |||
Significance | p < 0.0003 | p < 0.00001 | p < 0.00001 | |||
The Princess Alexandra Hospital NHS Trust | ||||||
In-Patient Admissions | ||||||
Population | 71,000 | 800 | 2900 | 2800 | 2100 | |
Cases of IBD | 3710 | 27 | 118 | 8 | 37 | |
Expected Cases of IBD | 3710 | 42 | 152 | 146 | 110 | |
Proportion Statistic | −1.8 | −2.1 | −11.3 | −6.1 | ||
Significance | n.s. | p < 0.03 | p < 0.00001 | p <0.00001 |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Farrukh, A.; Mayberry, J. Apparent Disparities in Hospital Admission and Biologic Use in the Management of Inflammatory Bowel Disease between 2014–2018 in Some Black and Ethnic Minority (BEM) Populations in England. Gastrointest. Disord. 2020, 2, 144-151. https://doi.org/10.3390/gidisord2020015
Farrukh A, Mayberry J. Apparent Disparities in Hospital Admission and Biologic Use in the Management of Inflammatory Bowel Disease between 2014–2018 in Some Black and Ethnic Minority (BEM) Populations in England. Gastrointestinal Disorders. 2020; 2(2):144-151. https://doi.org/10.3390/gidisord2020015
Chicago/Turabian StyleFarrukh, Affifa, and John Mayberry. 2020. "Apparent Disparities in Hospital Admission and Biologic Use in the Management of Inflammatory Bowel Disease between 2014–2018 in Some Black and Ethnic Minority (BEM) Populations in England" Gastrointestinal Disorders 2, no. 2: 144-151. https://doi.org/10.3390/gidisord2020015
APA StyleFarrukh, A., & Mayberry, J. (2020). Apparent Disparities in Hospital Admission and Biologic Use in the Management of Inflammatory Bowel Disease between 2014–2018 in Some Black and Ethnic Minority (BEM) Populations in England. Gastrointestinal Disorders, 2(2), 144-151. https://doi.org/10.3390/gidisord2020015